Canopy Growth (TSE:WEED – Free Report) had its price objective decreased by Canaccord Genuity Group from C$2.50 to C$1.50 in a research report released on Monday morning,BayStreet.CA reports. Canaccord Genuity Group currently has a sell rating on the stock.
Separately, ATB Capital cut Canopy Growth from a “sector perform” rating to an “underperform” rating and decreased their target price for the stock from C$6.00 to C$4.00 in a research report on Tuesday, December 17th. Four equities research analysts have rated the stock with a sell rating and one has assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of C$5.40.
Check Out Our Latest Report on Canopy Growth
Canopy Growth Stock Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Articles
- Five stocks we like better than Canopy Growth
- What to Know About Investing in Penny Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Consumer Discretionary Stocks Explained
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.